Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBSCT and Allogeneic T-cell Infusion in Metastatic Melanoma
NCT00003552Phase 2Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 1999
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic lymphocytes in melanoma, sponsored by National Heart, Lung, and Blood Institute. Started Jan 1999; status: terminated.
02
Drugs
allogeneic lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00003552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003552.